COHN vs HIVE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 17, 2026

COHN

36.8
AI Score
VS
HIVE Wins

HIVE

52.5
AI Score

Investment Advisor Scores

COHN

37score
Recommendation
SELL

HIVE

53score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric COHN HIVE Winner
Forward P/E 8.15 62.8931 COHN
PEG Ratio 0 0 Tie
Revenue Growth 16.8% 73.5% HIVE
Earnings Growth 15.8% -99.9% COHN
Tradestie Score 36.8/100 52.5/100 HIVE
Profit Margin 5.8% -98.5% COHN
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD HIVE

Relative Price Performance (Last 90 Days)

COHN 1M: -8.3% · 3M: -24.0% HIVE 1M: +10.1% · 3M: -21.6%

Current Technical Phase

COHN

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.6%), weak momentum, RSI 34

RSI (14): 34.4 · Price: $10.11

HIVE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 51.3 · Price: $3.16

Fundamentals Snapshot

Metric COHN HIVE
Market Cap — —
Forward P/E 5.5 -6.2
Trailing P/E 2.1 —
Revenue (TTM) — —
Revenue Growth 0.2% 0.7%
Gross Margin 1.0% 0.4%
Operating Margin 0.2% -0.6%
EPS 4.71 -1.36
Dividend Yield 0.10% —

Frequently Asked Questions

Based on our detailed analysis, HIVE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.